Abbott Healthcare Products BV, Manufacturing, Science and Technology, Established Pharmaceuticals, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands.
J Pharm Biomed Anal. 2013 Feb 23;74:133-40. doi: 10.1016/j.jpba.2012.10.004. Epub 2012 Oct 26.
A screening method for trace analysis of potentially genotoxic alkylating compounds has been developed using butyl 1-(pyridin-4-yl) piperidine 4-carboxylate (BPPC) as a new, selective pre-column derivatization reagent for their subsequent analysis by hydrophilic interaction liquid chromatography (HILIC) hyphenated with tandem mass spectrometry (LC-MS/MS). The new derivatization reagent is a modification of 4-dimethylaminopyridine (4-DMAP) previously used for the determination of potentially genotoxic compounds. By using the new reagent the screening potential was enhanced without compromising reactivity. Derivatization at a high pH value was carried out and the reaction time at 60°C was 24h to anticipate for alkyl chlorides showing to be less reactive. The new reagent was designed to obtain reagent related fragmentation of the whole reagent as well as a side group of the reagent. Collision energies for detection of alkylating components derivatized using the new reagent are shown to be significantly more universal than with 4-DMAP. Neutral loss scanning on the fragmentation related to the build in side group remedies shortcomings in the screening for alkyl halides observed when using 4-DMAP. The new approach allows for screening of alkyl halides and alkyl sulfonates at trace levels down to 1 mg kg(-1) and target analysis at about a factor of 10 lower without a significant effect of the active pharmaceutical ingredient (API) matrix. The synthesis of the reagent, investigation of reactivity, the specificity of the fragmentation of derivatives and screening conditions in MS/MS analysis are described.
一种用于痕量分析潜在遗传毒性烷基化化合物的筛选方法已经开发出来,该方法使用丁基 1-(吡啶-4-基)哌啶 4-羧酸酯 (BPPC) 作为一种新的、选择性的预柱衍生试剂,用于随后通过亲水相互作用液相色谱 (HILIC) 与串联质谱 (LC-MS/MS) 分析。这种新的衍生试剂是以前用于测定潜在遗传毒性化合物的 4-二甲氨基吡啶 (4-DMAP) 的修饰。通过使用新的试剂,在不影响反应性的情况下提高了筛选潜力。在高 pH 值下进行衍生化,在 60°C 下反应 24 小时,以预测显示反应性较低的烷基氯。新试剂的设计目的是获得整个试剂以及试剂的侧基的试剂相关片段化。用于衍生化新试剂的烷基化成分的检测碰撞能表明比 4-DMAP 更通用。与内置侧基相关的片段化的中性损失扫描可弥补使用 4-DMAP 进行烷基卤筛选时观察到的不足。该新方法允许在痕量水平(低至 1mg/kg)下筛选烷基卤和烷基磺酸盐,并在不显著影响活性药物成分 (API) 基质的情况下,在大约低 10 倍的水平上进行目标分析。描述了试剂的合成、反应性研究、衍生物的片段化特异性以及 MS/MS 分析中的筛选条件。